Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.97
+0.44 (4.18%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Design Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $20 | Buy | Maintains | $20 | +82.32% | May 27, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $22 | Buy | Reiterates | $22 | +100.55% | May 19, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $20 | Buy | Maintains | $14 → $20 | +82.32% | May 18, 2026 |
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $18 → $21 | Buy | Reiterates | $18 → $21 | +91.43% | May 4, 2026 |
| Jefferies | Jefferies | Buy Initiates $10 → $15 | Buy | Initiates | $10 → $15 | +36.74% | Mar 16, 2026 |